YYD302
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for YYD302, covering 2017-12-11 to 2021-05-10. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee [Phase 3]